drugset / Trial / NCT00202566

Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris

NCT00202566

Phase 3 Completed 750 enrolled Servier
RandomizedParallel-groupDouble-blind

Summary

To test whether ivabradine when given in combination with atenolol is able to improve the exercise tolerance of patients with stable angina pectoris

Timeline

Start
2005-06
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivabradine Small molecule 7.5 mg Oral